ContractAdvisory Board Agreement • November 5th, 2010 • Medgenics, Inc. • New York
SCIENTIFIC ADVISORY BOARD AGREEMENTScientific Advisory Board Agreement • November 5th, 2010 • Medgenics, Inc. • New York
THIS AGREEMENT (the “Agreement”) dated as of 22 October 2008 (“Effective Date”) is made by and between Medgenics, Inc. located at 8000 Towers Crescent Drive, Suite 1300, Vienna, VA, 22182, USA (the “Company”); and
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 5th, 2010 • Medgenics, Inc. • Delaware
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of September 15, 2010 by and among MEDGENICS, INC., (the “Company”) and each of the individuals and entities listed on Exhibit A attached hereto (collectively, the “Investors” and each an “Investor”).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • November 5th, 2010 • Medgenics, Inc. • Delaware
THIS STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of the 1st day of May, 2010 by and among Medgenics, Inc. a Delaware corporation (the “Company”), and _____________________________________ (individually, a “Purchaser” and collectively, the “Purchasers”).
DATED 19th June 2007 and andAgreement • November 5th, 2010 • Medgenics, Inc. • England
MEDGENICS MEDICAL ISRAEL, LTD. a company having a place of business at Hanapach 12 Karmiel, Israel (hereinafter separately or together referred to as “the Company”).
SCIENTIFIC ADVISORY BOARD AGREEMENTScientific Advisory Board Agreement • November 5th, 2010 • Medgenics, Inc. • New York
THIS AGREEMENT (the “Agreement”) dated as of May 1 2006 (“Effective Date”) is made by and between Medgenics, Inc. located at of 8000 Towers Crescent Drive, Suite 1300, Vienna, VA, 22182. USA (the “Company”); and
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • November 5th, 2010 • Medgenics, Inc.
This Non-Exclusive License Agreement (hereinafter called “Agreement”), to be effective as of the 25th day of January, 2007 (hereinafter called “Agreement Date”), is by and between Baylor College of Medicine (hereinafter called “BAYLOR”), a Texas nonprofit corporation having its principal place of business at One Baylor Plaza, Houston, Texas 77030, and Medgenics, Inc., a corporation organized under the laws of Delaware and having a principal place of business at Hanapach 12, Karmiel 20101, Israel, and its Affiliates (hereinafter, collectively referred to as “MEDGENICS”).
Personal Employment AgreementPersonal Employment Agreement • November 5th, 2010 • Medgenics, Inc.
This Personal Employment Agreement (the “Agreement”) is entered as of this 20th day of April, 2006 (the “Effective Date”), by and between
Amendment to Employment Agreement Between MEDGENICS MEDICAL ISRAEL LTD., private company number 512919952,Employment Agreement • November 5th, 2010 • Medgenics, Inc.
By virtue of my power under Section 14 of the Severance Pay Law, 5723-1963 (hereinafter: the “Law”), I certify that payments made by an employer commencing from the date of the publication of this approval for the sake of his employee to a comprehensive pension provident fund that is not an insurance fund within the meaning set forth in the Income Tax Regulations (Rules for the Approval and Conduct of Provident Funds), 5724-1964 (hereinafter: the “Pension Fund”) or to managers’ insurance which includes the possibility to receive annuity payments under an insurance fund as aforesaid, (hereinafter: the “Insurance Fund”), including payments made by the employer by a combination of payments to a Pension Fund and an Insurance Fund (hereinafter: “Employer’s Payments”), shall be made in lieu of severance pay due to said employee with respect to the salary from which said payments were made and for the period they were paid (hereinafter: the “Exempt Salary”), provided that all the following co
AGREEMENTAgreement • November 5th, 2010 • Medgenics, Inc.
THIS AGREEMENT, made and entered into as of May 1, 2010, is by and between Hadasit Medical Research Services & Development Co. Ltd. (“Hadasit”), P.O. Box 12000, Jerusalem Israel 91120 and Medgenics Medical Israel, Ltd., a company with an address at Teradion Business Park, Misgav Israel 20179 (the “Company”).
CONSULTING AGREEMENTConsulting Agreement • November 5th, 2010 • Medgenics, Inc.
THIS CONSULTING AGREEMENT (this “Agreement”) is made and entered into as of August 17, 2010 (the “Effective Date”), by and between MEDGENICS, INC., a Delaware corporation (the “Company”), and EQUITY SOURCE PARTNERS, LLC (“ESP”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 5th, 2010 • Medgenics, Inc. • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of September 15, 2010, is by and among Medgenics, Inc., a Delaware corporation with offices located at 8000 Towers Crescent Dr., Suite 1300, Vienna, VA 22182 (the ”Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
CONSULTING SERVICES AGREEMENTConsulting Services Agreement • November 5th, 2010 • Medgenics, Inc. • California
This agreement (“Agreement”) is entered into as of January 31st, 2008 Medgenics, Inc. a corporation organized under the laws of Delaware (“Client”) and Biomondo Consulting, Inc., a corporation organized under the laws of the State of California (“Consultant”).
Amended and Restated Personal Employment AgreementPersonal Employment Agreement • November 5th, 2010 • Medgenics, Inc.
This Amended and Restated Personal Employment Agreement (the "Agreement") is entered as of the 1st day of June, 2007 (herein, "Effective Date"), by and between Medgenics, Inc., a company organized under the laws of the State of Delaware, USA ("Medgenics"), its wholly owned Israeli subsidiary, Medgenics Medical Israel, Ltd., a company organized under the laws of the State of Israel ("the Company"), having its principal office at Hanapach 12, Karmiel 20101 Israel, and Dr. Andrew Pearlman, of Moshav Shorashim D.N. Misgav 20164 (Israeli I.D. No. 015255136) (the "Employee").
ContractLicense Agreement • November 5th, 2010 • Medgenics, Inc.
Agreement for Clinical Trials (without CRO)Medgenics, Inc. • November 5th, 2010
This Agreement for Clinical Trials (without CRO) (hereinafter, this “Agreement”) is made this 18 day of March 2010 by and between Medgenics Medical Israel, Ltd., a company organized and existing under the laws of the State of Israel with offices at Misgav Business Park, Misgav, Israel (hereinafter - the Company), and The Medical Research, Infrastructure, and Health Services Fund of the Tel Aviv Medical Center, a ____________ organized and existing under the laws of the State of Israel with offices at _____________________ (hereinafter - the Fund), and Dr. Doron Schwartz, an individual residing at _________________________, and having Israeli I.D. No.: 5556763-0 (hereinafter - the Principal Investigator). Each of the Company, the Fund, and the Principal Investigator may be referred to herein as a “Party” and collectively as the “Parties”.
SERVICE AGREEMENT THIS AGREEMENT is entered into on April 26, 2010 (‘Effective Date”) by and betweenService Agreement • November 5th, 2010 • Medgenics, Inc.
WHEREAS, Company and RL wish to enter into a contract and agreement whereby RL will render certain work and services to and for the benefit of Company.
ContractOffshore Registrar Agreement • November 5th, 2010 • Medgenics, Inc. • Jersey
Consulting AgreementConsulting Agreement • November 5th, 2010 • Medgenics, Inc.
This Agreement is being made and entered into as of May 1, 2006, by and between Medgenics Medical Israel Ltd., an Israeli company of Rechov HaNapach 12 Karmiel (the “Company”), and Professor Amos Panet, residing at: 1l Shrim St., Apt. 21 Jerusalem (the “Consultant”).
SCIENTIFIC ADVISORY BOARD AGREEMENTScientific Advisory Board Agreement • November 5th, 2010 • Medgenics, Inc. • New York
THIS AGREEMENT (the “Agreement”) dated as of May 1 2006 (“Effective Date”) is made by and between Medgenics, Inc. located at of 8000 Towers Crescent Drive, Suite 1300, Vienna, VA, 22182. USA
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 5th, 2010 • Medgenics, Inc. • Delaware
THIS SECURITIES PURCHASE AGREEMENT (“Agreement”) is made as of the 13th day of May, 2009 by and among Medgenics, Inc. a Delaware corporation (the “Company”), and the Investors set forth on the signature pages affixed hereto (each an “Investor” and collectively the “Investors”).
Dear Sirs,Letter Agreement • November 5th, 2010 • Medgenics, Inc.
Personal Employment AgreementPersonal Employment Agreement • November 5th, 2010 • Medgenics, Inc.
This Personal Employment Agreement (the “Agreement”) is entered as of this 1st day of July, 2007 (the “Effective Date”), by and between Medgenics, Inc., a company organized under the laws of the State of Delaware, USA (“Medgenics”), its wholly owned Israeli subsidiary, Medgenics Medical Israel, Ltd., a company organized under the laws of the State of Israel (the “Company”), having its principal office at Hanapach 12, Karmiel 20101, Israel and Phyllis Bellin of Shorashim, Israel (Israeli I.D. No. 13009873) (the “Employee”).
PRODUCTION SERVICE AGREEMENTProduction Service Agreement • November 5th, 2010 • Medgenics, Inc. • California
THIS PRODUCTION SERVICE AGREEMENT (the “Agreement”), entered into and effective this 12th day of March, 2007 (the “Effective Date”), is by and between MOLECULAR MEDICINE BIOSERVICES, INC., located at 1890 Rutherford Road, Carlsbad, CA 92008 and MEDGENICS, INC. and MEDGENICS MEDICAL ISRAEL LTD. (“SPONSOR”) located at 8000 Towers Crescent Drive, Suite 1300, Vienna, VA 22182, USA and 12 HaNapach St. Karmiel, 21553 ISRAEL, respectively.
AGREEMENT Made on this 16 day of April 2007 (“Effective Date”) by and between MEDGENICS MEDICAL ISRAEL, LTD. A company organized and existing under the laws of Israel with offices at 12 HaNapach St. Karmiel, Israel (“MMI”) and MEDGENICS, INC. A...Agreement • November 5th, 2010 • Medgenics, Inc.
WHEREAS MMI has applied for funding from the OCS (as defined below) under the Law (as defined below) for an approved budget for the period commencing on June 1, 2006 and ending May 31, 2007 for the research and development projects titled Biopump: Medical device for preparation of autologous skin implants (OCS file Numbers 37503 and 37679)(the “Grants”); and
Personal Employment AgreementPersonal Employment Agreement • November 5th, 2010 • Medgenics, Inc.
This Personal Employment Agreement (the “Agreement”) is entered as of this 18th day of March, 2007 (the “Effective Date”), by and between
Dated 28 November 2007 andAgreement • November 5th, 2010 • Medgenics, Inc. • England
June 16, 2010Medgenics, Inc. • November 5th, 2010 • Florida
Reference is made to (i) that certain letter agreement between Medgenics, Inc., a Delaware corporation with its U.S. offices located at 8000 Towers Crescent Drive, Suite 1300, Vienna, VA 22182 (separately or together with its subsidiaries and affiliates referred to hereto as “Medgenics” or the “Company”) and Newbridge Securities Corporation, incorporated in the state of Virginia and headquarters at 1451 West Cypress Creek Road, Ft. Lauderdale, FL 33309 (“Newbridge”) dated February 26, 2009 relating to the private placement of Company securities (the “Private Placement Engagement Letter”) and (ii) that certain letter agreement between the Company and Newbridge dated February 26, 2009 relating to the proposed secondary public offering of Company common stock (the “Prior Secondary Engagement Letter” and together with the Private Placement Engagement Letter, the “Prior Agreements”). Newbridge and Medgenics acknowledge and agree that the rights and obligations under each of the Prior Agreem
CONSULTING AGREEMENTConsulting Agreement • November 5th, 2010 • Medgenics, Inc.
THIS CONSULTING AGREEMENT (this “Agreement”) is made and entered into as of June 1, 2010 (the “Effective Date”), by and between MEDGENICS, INC., a Delaware corporation (the “Company”), and THE NYBOR GROUP, INC. (“NGI”).
FIRST AMENDMENT TO THE AMENDED AND RESTATED PERSONAL EMPLOYMENT AGREEMENTPersonal Employment Agreement • November 5th, 2010 • Medgenics, Inc.
THIS FIRST AMENDMENT TO THE AMENDED AND RESTATED PERSONAL EMPLOYMENT AGREEMENT (this “Amendment”) is entered into this 1st day of June, 2008, by and between Medgenics, Inc., a Delaware corporation (“Medgenics”), its wholly-owned subsidiary, Medgenics Medical Israel, Ltd., a company organized under the laws of the State of Israel (the “Company”), and Andrew L. Pearlman (the “Employee”).
